pharmaceutical industry

Quality and Efficiency in Pharma Manufacturing

Current and Future Trends for Pharmaceutical Logistics

GDP goes Europe

Maximum Safety by Consistent Quality Management

Gartner findings: No Prospective for Global Solution

“Supply Chains are 3-dimensional Networks”

Teva Makes $40 Billion Cash-and-Stock Bid for Mylan

Quality and Efficiency in Pharma Manufacturing

Tomorrow’s Pharmaceutical Market?

There's been no trace of the original gold-digging market for a long time. The hyperbole and initial euphoria have been followed by disillusionment and stark reality.

Drugs Industry Battered by Currency and Competition

Merck & Co Analyst Pleads Guilty to Insider Trading

Bayer’s Brandicourt Could Be New Sanofi CEO

The Challenge of Increasing Internationalization

Camelot’s Pharma Management Radar

From Experts for Experts

Conquering A Global Problem

The EXCiPACT Certification Scheme

Discovering the Future of Pharma

Multichannel Excellence: The Competitive Factor for Pharma

Shire to Bow to AbbVie's Sweetened $53 Billion Offer

Mylan to Pay Abbott $5.3 Billion for Non-US Business

Pfizer-AstraZeneca Deal Still Occupies Analysts’ Fantasy

The Power Of Innovation

Process-Automation Trends - Achieving safe, reliable, profitable operations and networking with fellow users, industry and business leaders, system integrators, and representatives - these will be part of Yokogawa's Users Conference in Berlin from July 2 to 4.

Giving Pharma a Boost

Opportunities Through Biotechnology

New Valeant Bid Values Allergan at $49.44 Billion

Pfizer Abandons $118 billion AstraZeneca Takeover

AstraZeneca Shareholders at Odds over Pfizer Bid Rejection

AstraZeneca Rejects Pfizer’s ‘Final’ Takeover Offer

US Court Dismisses Teva Case to Block Generic Copaxone

AstraZeneca CEO ‘Would Engage With Pfizer’ for the Right Price

Pfizer Hits Back at Criticis of Proposed AstraZeneca Deal

Maximum Return on Surplus and idle assets

UK Prime Minister Calls on Pfizer for More Guarantees

Devalued and Distrusted